Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD4017 in idiopathic intracranial hypertension
2013-003643-31Phase 2Completed
- Sponsor
- University of Birmingham
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in idiopathic intracranial hypertension (IIH) comparing AZD4017 with Placebo (2 arms). Primary endpoint: Change in intracranial pressure. Started Dec 2013; status: completed.
02
Drugs
AZD4017
03
Conditions
idiopathic intracranial hypertension (IIH)
Beyond the preview
Go deeper on 2013-003643-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003643-31.